Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Xiamen Amoytop Biotech Co., Ltd.

Clinical trials sponsored by Xiamen Amoytop Biotech Co., Ltd., explained in plain language.

Trials to join now! 2 Not yet recruiting 2 Completed 2
Sort by
  • Weekly shot could replace daily injections for growth-stunted kids

    Disease control Recruiting now

    This study tests whether a once-weekly injection of a new growth hormone (inpegsomatropin) works as well as the standard daily growth hormone shot in children who were born small for their age and remain very short. About 141 prepubertal children will receive one of two doses of …

    Phase: PHASE3 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control

    Last updated May 01, 2026 16:00 UTC

  • New hope for rare blood cancer patients: experimental drug targets uncontrolled platelet counts

    Disease control Recruiting now

    This study tests two doses of peginterferon alfa-2b in 27 adults with essential thrombocythemia, a rare blood cancer causing too many platelets. Participants have not responded well to or cannot tolerate the standard drug hydroxyurea. The goal is to see which dose works better an…

    Phase: PHASE2 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control

    Last updated Apr 29, 2026 15:02 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space